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Abbreviations 
AA : Alpha acids 
ABV : Alcohol By Volume 
ASCA : ANOVA simultaneous component analysis  
C : Control beverage (soft drink) 
IAA : Iso-α-acids 
IBU : International Bitterness Units 
LB : Light beer 
MSt1 : Meal Study 1 
MSt2 : Meal Study 2 
NMR : Nuclear magnetic resonance spectroscopy 
NMT : N-methyl tyramine 
pGlu-Pro : Pyro-glutamyl proline  
PLSDA: Partial least squares discriminant analysis 
RB : Regular beer 
SCA : Simultaneous component analysis 
SS : Sum of squares 
UPLC-MS : Ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry  
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Abstract 
Evaluation of health related effects of beer intake is hampered by the lack of accurate tools for 
assessing intakes (biomarkers). Therefore, we identified plasma and urine metabolites associated with 
recent beer intake by untargeted metabolomics and established a characteristic metabolite pattern 
representing raw materials and beer production as a qualitative biomarker of beer intake. In a 
randomized, crossover, single-blinded meal study (MSt1) 18 participants were given one at a time four 
different test beverages: strong, regular and non-alcoholic beers and a soft drink. Four participants were 
assigned to have two additional beers (MSt2). In addition to plasma and urine samples, test beverages, 
wort and hops extract were analyzed by UPLC-QTOF. A unique metabolite pattern reflecting beer 
metabolome, including metabolites derived from beer raw material (i.e. N-methyl tyramine sulfate and 
the sum of iso-α-acids and tricyclohumols) and production process (i.e. pyro-glutamyl proline and 2-
ethyl malate) were selected to establish a compliance biomarker model for detection of beer intake 
based on MSt1. The model predicted the MSt2 samples collected before and up to 12 h after beer 
intake correctly (AUC = 1). A biomarker model including four metabolites representing both beer raw 
materials and production steps provided a specific and accurate tool for measurement of beer 
consumption.  
 
 
 
Keywords: Beer, Barley, Hops, Biomarker model, Hops, Metabolomics, Plasma, Urine, UPLC-QTOF 
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Introduction 
Light to moderate alcohol consumption has been associated with decreased total mortality and with 
lower risk of metabolic diseases such as diabetes and cardiovascular disease1, 2, but also with adverse 
effects on certain cancers3. The health related effects of consuming alcoholic beverages are mostly 
attributed to their alcohol content rather than specific components of different kinds of beverages, 
although there are some contradictory findings4, 5. One of the major issues in alcohol research is the 
assessment in observational studies of the consumption of specific alcoholic beverages usually obtained 
using self-reported questionnaires. These tools may provide only moderately reliable information, since 
reporting may be influenced by cultural and personal views on alcohol. Biomarkers of food intake are 
powerful tools for assessment of dietary exposure in clinical and observational studies. Some recent 
studies suggested resveratrol and isoxanthohumol as intake biomarkers for wine and beer consumption, 
respectively6, 7. However, resveratrol is also found in grapes and berries and isoxanthohumol has a 
highly variable rate of biotransformation into 8-prenylnaringenin (0-100% conversion) in the human 
gut making it a less than ideal biomarker8, 9. 
Beer is one of the most widely consumed beverages and is a very complex food with a metabolome 
originating from raw materials (e.g. barley and hops) and their transformation products formed during 
malting, boiling and fermentation. Consumption of beer may lead to direct absorption of its 
components but quite often their degradation or biotransformation products have also to be taken into 
consideration. Hops may be the most characteristic ingredient in beer and therefore the best candidate 
for single biomarker search strategies10. Iso-α-acids (IAAs) from hops, are specific to beer11, 12 yet one 
major issue with IAAs as biomarkers is their high susceptibility to degradation, leading to multiple 
products; therefore their quantity varies after storage13, 14. In terms of metabolism of IAAs, only limited 
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number of studies is available15, 16. Therefore investigating the fate of not only IAAs but also their 
oxidation products in the human body would be a prerequisite for finding a suitable hops-derived 
biomarker.  
Basic steps and raw materials in beer production are mostly universal, yet production processes by 
different producers vary, thereby further complicating the search for a global beer biomarker. 
Furthermore, human individuals differ with respect to many biotransformation pathways, making it 
even more challenging to find any single biomarker that is universal for beer intake. Finding markers 
representing each common raw material and step in beer production and mapping their 
biotransformation may therefore be a strategy to design more global aggregated biomarkers, 
representing the complete process. Beer as well as alcohol may affect metabolism by altering the 
glucose and insulin responses17,18 and these parameters are therefore of potential importance as 
modifiers of biomarker responses. 
Metabolomics resulting from the development of highly sensitive modern analytical instruments is an 
attractive tool for identification of novel intake biomarkers for specific diets, foods, food constituents 
and/or for further assessment of their health impacts19-22. This technology together with chemometrics 
also allows the identification of metabolite patterns as markers of intake19. Therefore, utilizing an LC-
MS based metabolomics and chemometrics approach we aimed here to identify the plasma and urinary 
metabolites associated with recent beer intake and establish a novel and validated aggregated 
biomarker produced by combination of identified metabolites that represent each of the raw materials, 
processing steps, thereby ascertaining uniqueness to beer intake.  
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Materials and Methods  
Subjects 
37 healthy subjects within an age range of 18-60 years were recruited from the greater Copenhagen 
area by bulletins at educational institutions and on public websites for recruiting volunteers for clinical 
studies. Exclusion criteria were the following: systemic infections, psychiatric conditions and 
metabolic disease; alcohol intolerance; alcohol intake above the Danish Health and Medicines 
Authority’s recommended limits of 7 and 14 units per week for females and males, respectively; 
donation of blood (>24 ml) less than 3 months before the study; breast feeding or pregnancy.  
The subjects were given both verbal and written information about the study before providing their 
written consent. The study was carried out at the Department of Nutrition, Exercise and Sports, Faculty 
of Science, University of Copenhagen, Frederiksberg, Denmark. The research protocol was approved 
by the Ethical Committee of the municipalities of Copenhagen and Frederiksberg (H-1-2013-029) and 
the study has been registered at clinicaltrials.gov (NCT02449577). 
Study Designs and Diets 
Meal study 1(MSt1): 19 subjects were included in the main part of the study. A formal power 
calculation is not possible for explorative studies but several previous meal studies have indicated that 
10-20 volunteers suffice. The study was performed as a randomized, crossover, single-blinded 
intervention with four study periods of three days and a wash-out period of >1 week between periods. 
The four periods consisted of a test day where subjects were served with one of the three different test 
beers or a control beverage in randomized order. The three test beers were a strong lager (SB) 
(Carlsberg Elephant, 8 % ABV, ~35 IBU), a regular lager (RB) (Carlsberg Pilsner, 4.6 % ABV, ~22 
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IBU), and a light/alcohol-free beer (LB) (Tuborg Super Light 0.1 % ABV, ~19 IBU). The control soft 
drink beverage (C) (Carlsberg Sports drink) was alcohol free but with the same energy content 
(carbohydrate and protein) as the average of the test beers. 
The evening before the test day, subjects consumed a standardized dinner (spaghetti Bolognese) with 
water ad libitum. On the test day, after having a standardized breakfast (bread, butter, ham, cheese, 
orange juice) ad libitum between 7-8 am, subjects were instructed to fast for 3-4 hours (except for ~½ 
liter of water). Subjects were served a standardized lunch of Parisian toast/grilled cheese sandwiches 
(Tulip Food Company) at 11.35 am together with one of the test beers or the C (330 ml), all to be 
consumed within 25 min. The amount of toast was adjusted according to the type of drink served, so 
that the content of macronutrients was the same in each meal. Until 2.35 pm (last blood sampling) 
subjects did not consume any food or drink, but had water ad libitum. Thereafter, subjects were 
allowed to consume their habitual diet but were instructed to abstain from intake of alcohol in any form 
for 24 hours after the start of each test day (i.e. until 8 am in the following morning). They were 
otherwise instructed to retain their usual pattern of alcohol intake during the remaining 4 weekdays 
between each of the four test periods.  
Meal study 2(MSt2): Four subjects were included in a second (validation) study; one of them also 
participated in the MSt1. The study was performed as a randomized, crossover intervention with all the 
same details as for MSt1, except that only two study periods of three days were conducted. The two 
periods consisted of a test day where subjects were served with two servings (660ml) of either of the 
two test beers in randomized order. Two test beers were used; one being a high hops moderate alcohol 
beer (HHB) (Lawn Mower, Carlsberg breweries, Sweden, 4.8 % ABV, ~31 IBU) and the other a low 
hops high alcohol beer (LHB) (T-beer, Tuborg breweries, Romania7-8 % ABV, ~8 IBU). These beers 
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were selected as extremes with regard to the two main raw materials in beer to serve as a test for the 
validity of the biomarker development concept. 
On the test day volunteers in the MSt2 validation study had a standardized breakfast and lunch 
(multigrain bread containing also barley, cheese, ham, a red pepper fruit, radishes, apple, banana, 
orange juice and egg) according to calculated energy needs, and consumed the same standardized 
dinner together with 660 ml of either of the test beers. The following day, they consumed the same 
standardized meals but not the test beers.   
In both studies volunteers were allowed otherwise to remain on their habitual diets, but were required 
to abstain from drinking all forms of alcohol and avoid heavy physical activity from 48 and 24 hours 
before the test days, respectively.  
A simple randomization was used in both studies. The brewery delivered the four drinks in dark bottles, 
marked A, B, C, D for MSt1 and E and F for MSt2. A sequence table was generated for all volunteers 
so that they received the drinks in random order within each study. In principle participants, care 
providers and assessors were all blinded, however the participants could easily taste the nature of the 
soft drink. They were instructed not to tell the care providers. 
Blood and Urine Sampling  
Blood samples were drawn only in MSt1 on each test day 20 min before (baseline) and 0.45, 2 and 3 h 
after the subjects consumed the test beverages together with a standardized lunch. The blood samples 
were transferred into 4 mL vials containing heparin as an anticoagulant. The blood was centrifuged at 
3,000 g, 4°C for 10 min. The plasma fraction was aliquoted into 2 mL cryotubes and stored at −80°C 
until further processing.  
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Urine samples were collected on each test day within the following time periods: from their morning 
void until 20 min before having their test drink (baseline); from baseline until 1.5 h; from 1.5 h to 3 h; 
and from 3 h to 21 h. In addition, 24 h pooled samples were created as a mixture of the urine samples 
collected in the four different time intervals in relative proportion to their volumes.  
For the MSt2, only urine samples were collected: from lunch to dinner before having the test beer 
(baseline), baseline to 2 h, 2h to 4 h, 4h to 12 h, 12 h to 24h and 24 h to 40 h. 
During sampling, urine was stored below 5 °C in cooling bags and after completion, sample aliquots 
were kept at -80 °C until further analysis. 
Blood glucose and serum insulin 
The blood samples were collected in dry tubes for the measurement of insulin and in fluoride citrate 
tubes for the measurement of glucose. Plasma glucose was measured with an enzymatic colorimetric 
method (ABX Pentra Glucose HK CP; Horiba, Montpellier, France) and analyzed with an ABX Pentra 
400 (Horiba). Serum insulin was measured by a chemiluminescent immunometric assay with an 
Immulite 1000 Immunoassay System (Siemens Healthcare Diagnostics, West Sacramento, CA). All 
samples were analysed in one batch. Intra-assay and interassay coefficients of variation (CVs) for 
glucose and insulin were below 2.8%. 
UPLC-QTOF Analysis 
Plasma protein precipitation, urine centrifugation and dilution procedures were performed as described 
previously 23, 24. The 288 plasma samples and 320 urine samples were placed in 96-well plates, such 
that all samples (urine or plasma) from the same individual were in the same plate (analytical batch) 
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while the individuals were randomized between batches (five per batch) and the order of samples was 
randomized within each batch. An ultra-performance liquid chromatography (UPLC) system coupled to 
a quadrupole time-of-flight mass spectrometer (Premier QTOF, Waters Corporation, Manchester, UK) 
was used for sample analysis. The mobile phase was 0.1% formic acid in water (solvent A) and 0.1% 
formic acid in 70% acetonitrile and 30% methanol (solvent B). Five µL of each sample were injected 
into a HSS T3 C18 column (2.1 x 100 mm, 1.8µm) coupled with a VanGuard HSS T3 C18 column (2.1 
x 5mm, 1.8µm) and the gradient was operated for 7.0 min. The eluate was analyzed by electrospray 
ionization (ESI) in positive and negative mode, applying a capillary voltage of 3.2 kV and 2.8 kV, 
respectively and cone voltage of 20 kV. Ion source and desolvation gas (nitrogen) temperatures were 
set to 120 and 400°C, respectively. More detail on UPLC-QTOF analysis conditions can be found 
elsewhere25. Blanks (5% of acetonitrile:methanol 70:30 v/v in water) and external metabolomics 
standard mixtures were injected after every 30 samples, throughout each analytical batch25. 
In addition to plasma and urine samples, the test drinks, a beer wort extract, and hops extracts were 
analyzed with UPLC-QTOF using identical conditions. Sample preparation was comprised of dilution 
in solvent A for test drinks and wort whereas a mixture of solvent A and B (50-50 %) was used for 
dilution of the hops extract.  
MS/MS fragmentation experiments were conducted for structural characterization of beer intake 
markers. The collision-induced dissociation (CID) was set to 10, 20 and 30 eV in separate runs and all 
other parameters were kept as for the MS full scan experiments as described above. 
Data Preprocessing 
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Initially, raw data were converted to intermediate MZdata using an R function (convert.waters.Rd, 
https://github.com) operating on R software (ver. 3.1.0.). MZdata files were imported into MZmine 
2.10 for data preprocessing including the following steps: mass detection, chromatogram builder, 
chromatogram deconvolution (local minimum search), isotopic peaks grouper, peak alignment (join 
aligner), duplicate peak filter, peak list row filter and gap filling (peak finder). The term ‘feature’ is 
used to refer to an ion with a specific retention time and mass over charge ratio (m/z) throughout this 
paper.  
MZmine-preprocessed data were imported into MATLAB R2013a (ver. 8.1.0.604). Feature filtering 
was applied based on three criteria. First, the features detected earlier than 0.3 min and later than 6 min 
were removed. Second, if a feature has a significant peak area (>60, approx. 6 times the maximal 
background noise) in the first blank sample in at least one of the analytical batches, the feature was 
removed from the entire set as background noise. Third, if a feature had a peak area lower than 10 
(considered as noise level or gap filling errors), in more than 60% of the samples within every sample 
group (specified with one test drink type and one time point), the feature was excluded (percent rule). 
Urine samples were normalized to unit-length normalization to correct for urine concentration 
variations. Later, to remove inter-batch variation, each feature detected in urine/plasma samples within 
each batch was divided with the overall mean of its recordings included in the entire batch. This 
approach is justified by randomization of individuals between batches and of all samples from each 
individual within the same batch prior to analysis. Application of these pre-processing and 
normalization procedures separately on negative and positive mode data was followed by concatenation 
of the datasets from the two modes. In order to ease identification, features within the retention time 
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range of 0.02 were grouped and assigned as one feature group if they had correlation coefficients 
higher than 0.7. Then, each feature group is considered as representation of one unique compound. 
Data Analysis 
ASCA 
Data analysis was performed in MATLAB R2013a (ver. 8.1.0.604). For the plasma samples the 
baseline level of each feature was subtracted from its subsequent recordings at each time point (0.45, 2 
and 3 h) in order to reduce the influence of intra-individual factors.  For urine, this procedure did not 
affect the outcome and was therefore omitted (data not presented). 
Unit scaled data were subjected to, ASCA (ANOVA Simultaneous Component Analysis)26, to isolate 
and further investigate the variation related to test drinks and to identify the contributions of time 
course and test drink × time interactions.  
In order to evaluate the significance of ASCA decomposed effect matrices, a permutation test was 
employed 27. The permutation test is based on comparison of sum of squares (SS) of each effect matrix 
with SS distribution of matrices obtained with repeated random permutation of class labels. In this 
case, the number of permutations was 100,000. The significance of each effect matrix was determined 
as the fraction of data permuted matrices that had SS higher than the SS of the original effect matrix.  
Later, simultaneous component analysis (SCA) was applied on individual effect matrices to interpret 
the associated variation. SCA provides information only on the level averages, and to analyze the 
variation between samples within each level, the residuals were projected on the principal component 
subspace of effect matrices, as described previously28.   
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An approach similar to ANOVA-PCA was carried out, where the residual matrix was added to test 
drink effect matrix 20, 28. This provided the basis data matrix for the subsequent PLSDA.  
ASCA was performed with in-house developed MATLAB functions.  
PLSDA 
PLS_Toolbox (version 6.5, Eigenvector Research, Inc., MA, US) was used for partial least squares 
discriminant analysis, PLSDA. PLSDA was applied to differentiate the plasma and urine metabolic 
patterns associated with beer intake (i.e. SB+PB+LB vs. C) within the consumed beers. In order to 
validate PLSDA models, ten different test sets each comprised of data from all samples (time points 
and treatments) from all possible combinations of two subjects were set aside. Variable selection was 
performed repeatedly by removing variables with selectivity ratio and variable importance in projection 
(VIP) values lower than 1 until no further increase in the cross-validation (eight-fold) classification 
errors could be observed. Final models with selected variables were evaluated using test set 
misclassification29. The variables that were selected in at least seven of the models were assigned as 
markers of beer intake. 
Calibration and validation models 
The calibration set was created from MSt1 including only the measurements of the selected metabolites 
for urine collected at 0-1.5 h, 1.5-3 h and 3-21 h. PLSDA was applied on the calibration set to 
discriminate the three beers (SB+RB+LB) from the soft drink, C. PLSDA models were built with 1 to 5 
LV and optimum model complexity (i.e. number of components) was decided by evaluating 
misclassifications. This PLSDA model is used as the calibration model. MSt2 with the measurements 
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of selected metabolites for four subjects was used as the test set to validate the calibration model. The 
evaluation was based on how well the calibration model performs in classifying MSt2 samples 
collected after beer intake within the beer periods (i.e. SB+RB+LB in MSt1), as well as classifying 
MSt2 samples collected before beer intake within C (MSt1). Models were assessed by diagnostic 
statistics, area under receiver operating characteristic curve (AUC) and misclassification rate.  
Standards and Identification 
Four levels of chemical identification according to the published guidelines for chemical analysis were 
used 30. Amino acids (i.e., tyrosine, leucine/isoleucine, proline) and the dipeptide pyroglutamyl proline 
(pGlu-Pro) were identified using an in-house metabolite database containing retention time information 
and MS spectra of reference substances. Reference standards for ICS-I3 (containing 62.3 % w/w of 
trans-IAA) and ICE-3 (containing 44.64 % w/w of AA) were obtained from Labor Veritas (Zurich, 
Switzerland). Isoxanthohumol and naringenin were purchased from Sigma (Schnelldorff, Germany). 
For unknown compounds with a signal area higher than 600, MS/MS spectra (10, 20 and 30 eV) were 
recorded in order to obtain fragmentation information to compare with data in available databases, such 
as Metlin (https://metlin.scripps.edu), hmdb (http://www.hmdb.ca), Chembank 
(http://chembank.broadinstitute.org/welcome.htm), Chemspider (http://www.chemspider.com), and 
similar sites. All six test drinks and beer wort and hop extract were kindly provided by Carlsberg A/S.  
NMR analysis 
The presence and identity of the dipeptide pGlu-Pro in beer was verified by 2D homo- and 
heteronuclear high-resolution NMR spectroscopy using beer fractionated by preparative UPLC. To this 
end, lyophilized UPLC fractions containing compound with a mass consistent with possible pGlu-Pro 
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were redissolved in 500 µL D2O (Cambridge Isotope Laboratories, Andover, MA, USA).  NMR 
spectra including 1H-13C HSQC and 1H-1H TOCSY were recorded on a Bruker Avance II 800 MHz 
spectrometer equipped with a TCI Z-gradient CryoProbe and an 18.7 T magnet (Oxford Magnet 
Technology, Oxford, U.K.). All NMR spectra were recorded, processed and analysed with Bruker 
Topspin 2.1 (Fällanden, Switzerland). 
Selection of the aggregated biomarker for beer intake 
Initially, the origin of each compound associated with beer intake was grouped based on their origin. 
This is accomplished by comparing m/z and retention time of each beer marker with m/z and retention 
time of the compounds detected in test beers, hops extract and wort reference samples.  Accordingly, 
beer intake markers were divided into four groups, originating from (1) hops, present only in hops 
extract and test beers, (2) wort, present only in beer wort and test beers, (3) fermentation related 
markers, present only in beer but not in hops or wort, (4) human metabolism of beer components, 
present only in urine and plasma but not in beers, wort or hops. Since beer is a processed and complex 
beverage, none of the markers originating from beer raw materials or their processing individually may 
suffice as sufficiently specific and sensitive beer intake biomarkers. An aggregated biomarker 
combining each raw material and process was therefore constructed based on the principle that each 
included biomarker must be identified chemically and present as a signalling exposure marker clearly 
increasing after intake of each kind of beer while having much smaller or undetectable levels in the 
control period.   
The calibration set for this aggregated biomarker was built from MSt1 including only the 
measurements of the four selected metabolite groups in the 24 h pooled urines from each period and 
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from each of the 18 subjects. A PLSDA model with one component was established as the calibration 
model. The performance of the calibration model was evaluated using metabolome profiles from MSt2 
(validation set), which had not been used in model development and optimization. The validation set 
included the measurements of the four selected metabolite groups in urine samples collected before (as 
control) vs. 0-2 h, 2-3 h and 3-12 h after beer intake (representing beer intake) for all four individuals. 
Results  
Recruitment started April 2013 and the trials ended November 2013. A total of 18 completers in MSt1 
were included in the analyses. One subject dropped out after the first out of four periods, because she 
did not have enough time to participate anymore. All four completers in MSt2 were included. Data 
acquisition ended in August 2014. The trials ended as scheduled. We report here only the primary and 
some secondary aims according to the protocol. Baseline characteristics of the subjects are recorded in 
Table 1. No adverse events for the trial were recorded. 
Table 1. Participant characteristics of MSt1 and MSt2 at the time of enrollment 
 MSt1 (n = 19) MSt2 (n = 4) 
Female [ n ( % )] 9 (47) 2(50) 
Age Range 24-50 28-60 
BMI 23.3±5.1 22.4±3.4 
Blood Pressure (mm Hg)   
Systolic blood pressure 110.2±6.5 113.7±8.1 
Diastolic blood pressure 62.0±8.0 75.7±11.4 
Habitual Alcohol Consumption1 [n]   
Moderate (1-2 drink/day)  11 2 
Low (or abstained) (<1 drink/day) 7 2 
 
Fasting whole-blood glucose and serum insulin levels were not different between treatments. There 
were no significant differences between treatments when glucose and insulin response were expressed 
in terms of total or incremental AUC. 
1The levels of alcohol consumption is adapted from on NIH 
Page 16 of 48
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  17 
Selection of metabolites associated with beer intake 
The number of samples for plasma was 216 (i.e. 18 subjects × three time points × four test drinks) and 
360 for urine samples (i.e. 18 subjects × (four time points + pool) × four test drinks). A total of 1503 
and 8935 features remained after feature filtering for plasma and urine samples, respectively.  
ASCA partitioned the total variation into contributions of corresponding experimental factors (i.e. test 
drink and time) and their interaction. A permutation test was applied in order to validate the ASCA 
factor models. Comparing the SS of 100,000 random class assignments with SS calculated from the 
original classes for each effect matrix, revealed that only the two main effects, time and test drink, were 
significant (P<0.0001), but not the interaction between time and test drink (P>0.7) (Figure S-1 and S-
2). The percentage of explained variation of each factor was calculated as the SS of decomposed factor 
matrices (Table S-1).  
SCA scores plot (Figure 1) displays the separation of the samples at the test drink level both for urine 
and plasma. For urine, the separation of beer samples was mainly explained by PC1, with lower PC1 
score values for beer samples compared to C. On the other hand, for plasma the dominating factor was 
alcohol, explained by PC1, and the combination of PC1 and PC2 provides the separation of beer intake. 
SCA scores plots for individual factors and their interaction are also given in Supplemental Material 
(Figures S-3 and 4).  
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Figure 1. SCA score plot of the test drink matrix for both the urine (top) and plasma (bottom) 
metabolic profiles. An SCA model was applied to the effect matrix obtained from the ANOVA 
decomposition. 
PLSDA was applied on the matrix where residuals were added to the decomposed test drink factor 
matrix. Three beers are assigned as one group providing a binary classification problem (i.e. 
SB+PB+LB vs. C). The mean of misclassification errors of selected test sets for plasma and urine were 
significantly higher than classifications errors of 1000 random class assignments (P-values were 0.04 
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for plasma and 0.004 for urine).  The potential beer intake markers were selected by evaluating VIP 
values and selectivity ratio. 
Assessment of the origin of putative beer intake biomarkers 
Sixty nine compounds associated with beer intake were grouped based on their presence in test beers, 
wort and hops extracts as described in the Materials and Methods section. This comparison revealed 15 
compounds originating directly from the hops extract (two in both plasma and urine, 13 only in urine), 
19 directly from wort (one in both plasma and urine, three only in plasma, 14 only in urine), 2 from 
fermentation (only observed in urine) and 20 from human biotransformation (one only in plasma and 
19 only in urine). The identified compounds are given in Table 2 and the list of unknown compounds 
and their source is given in Table S-2. 
Table 2. Identified plasma and urine metabolites originating from beer raw materials hops and wort, 
fermentation process and human and/or microbial biotransformation of beer components. 
No m/z RT MS/MS  Annotation Suggested 
Compound* 
Biofluid Specificity to 
beer intake/ 
Source** 
1 363.18 4.08 
4.17 
4.2 
4.24 
too low 
signal 
[M-H]- Hydroxy alloiso-
cohumulone and/or 
cohumulinone3 
Urine S/hops 
2 365.19 
  
4.15 
4.22 
4.27 
347.1,269.1 
251.1,237.1 
209.1,193.1 
181,141 
[M-H]- Tetra-cyclocohumol 
and/or tri-
cyclocohumol3  
 
Urine S/hops 
3 377.182 
379.192 
4.27 
4.34 
4.2 
too low 
signal 
[M-H]- 
[M+H]+ 
 
Hydroxy alloiso-
ad/humulones 
and/or 
ad/humulinone3 
Urine S/hops 
4 379.21 
 
4.29 
 
361.2,310.1 
283.1,265.1 
223.1,207.1 
[M-H]- Tetra-
cycload/humol2 
 
Urine S/hops 
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195.1,155.1 
5 379.21 4.38 
4.51 
too low 
signal 
[M-H]- Tri-cycload/humol 
and/or  
double hydroxylated 
iso-cohumulone3 
Urine S/hops 
6  347.19 
 
 
 
4.53 
 
 
 
329.2,285.2 
259.1,253.2 
235.2,217.1 
183.1,165.1 
[M-H]- Iso-
tricyclocohumene2 
 
Urine 
 
S/hops 
7 347.19 
 
4.61 329.2,279.1 
251.1,233.1 
209.1,181.1, 
182.1 
[M-H]- Iso-cohumulone1 Urine 
Plasma 
S/hops 
8 361.20 
 
4.59 
 
343.2,299.2 
259.1,223.1 
197.1,179.1 
[M-H]- Iso-
tricycload/humene2 
 
 
Urine 
 
S/hops 
9 361.20 
 
4.66 343.2,265.2 
247.1,223.1 
196.1,195.1 
[M-H]- Iso-n/ad-humulone1 Urine S/hops 
10 393.19 3.78 
3.83 
375.2,281.1 
263.1,223.1 
196.1,195.1 
[M-H]- Dihydroxylated iso-
ad/humulone2 
Urine S/hops 
11 393.182 3.82 too low 
signal 
[M-H]- Dihydroxylated iso-
ad/humulone II3 
Urine S/hops 
12 377.162 4.15 too low 
signal 
[M-H]- NO or CH2O adduct 
of iso-cohumulone3  
M7 + 30.0 
Urine S/metabolised 
hops  
13 391.176 4.19   
4.28 
4.42 
347.2,329.2 
303.2,292.1 
265.1,247.1 
196.1,195.1 
163.1,125 
[M-H]- NO or CH2O adduct 
of iso-ad/humulone3  
M8 + 30.0  
Urine S/metabolised 
hops 
14 393.149
  
3.62 
3.58 
331.1,316.1 
314.2,267.1 
249.1,219.1 
195.1,182.1 
149.1,111.1 
[M-H]- NO2 or CH2O2 
adduct of iso-
cohumulone3 
M7 + 46.0 
Urine S/metabolised 
hops 
15 407.174 
 
3.78 
3.66 
3.72 
389.2,345.2 
315.2,295.1 
277.1,245.1 
233.1,223.1 
195.1,175 
149.1,99.1 
[M-H]- NO2 or CH2O2 
conjugate adduct of 
iso-ad/humulone3  
M8 + 46.0 
 
Urine S/metabolised 
hops  
16 514.176 3.41 too low 
signal 
[M-H]- Cysteine conjugate 
of NO2 or CH2O2 
adducted iso-
cohumulone3 
M7 + 45.98 + 
Urine S/metabolised 
hops  
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121.017  
17 528.191 3.47 407.1,363.2 
351.1,345.2 
281.1,245.1 
[M-H]- Cysteine conjugate 
of NO2 or CH2O2 
adducted iso-
ad/humulone3 
M8 + 45.98 + 
121.017 
Urine S/metabolised 
hops 
18 335.044
  
2.26  
301.1 
289 
243 
193  
175  
159  
 
131 
125  
113,103,73 
[M -H]- 
[M -H2S]
- 
[M -COOH2]
- 
 
[Glucuronide+H2O]
- 
[Glucuronide-H]- 
[M-Glucuronide-H]-  
(C6H7O3S) 
 
[M-Glucuronide-
H2S]
- 
Unknown I 
Glucuronide I4 
Urine NS/metabolised 
beer 
component 
19 335.044
  
2.47  
317 
301  
247 
193 
175  
159  
 
131 
125  
113,87,73 
[M-H]- 
[M-H20]
- 
[M-H2S]
- 
 
[Glucuronide+H2O]
- 
[Glucuronide-H]- 
[M-Glucuronide-H]- 
 (C6H7O3S) 
 
[M-Glucuronide-
H2S]
- 
 
Unknown I 
Glucuronide II4 
Urine NS/metabolised 
beer 
component 
20 238.969
  
1.95  
175 
159  
141 
131 
125  
115.3,103 
97,87.1, 
80.9 
[M-H]- 
[Sulfate-H]- 
[M-Sulfate-H]- 
(C6H7O3S) 
[M-Sulfate-H2O]
- 
 
[M-Sulfate-H2S]
- 
 
Unknown I Sulfate4 Urine NS/metabolised 
beer 
component 
21 435.139 
 
2.11 
 
 
259.1  
175.02  
153.1,129 
117,113 
103,99 
95,85 
[M -H]- 
[M-Glucuronide-H]- 
[Glucuronide-H]- 
 
Unknown II 
Glucuronide4 
Urine NS/metabolised 
beer 
component 
22 303.071 1.97  
261.1 
175 
[M -H]- 
[M-C2OH2]
- 
[Glucuronide-H]- 
Unknown III 
Glucuronide4 
Urine NS/metabolised 
beer 
component 
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127 
117,113,99 
85,71,59 
[M-Glucuronide-H]- 
 
23 290.072 
312.053 
164.042 
162.022 
127.042 
122.029 
2.62 
 
too low 
signal 
[M+H]+ 
[M+Na]+  
[M+H-126.03]+   
[M-H-126.03]- 
[M+H-163.03]+ 
[Cysteine + H] + 
Mercapturic acid 
conjugate of 
Unknown IV4  
Urine NS/metabolised 
beer 
component 
24 365.105 
127.037 
325.116 
332.118 
97.0292 
85.0301 
0.88  [M+Na]+  
[M-C6H15O8]
+  
 
[M-OH]+  
 
Maltose2 Urine NS/ 
Malting or 
Mashing 
25 225.089 
227.104 
1.93  
 
ESI+:209.1 
181.1, 
116.1  
70.1 
ESI - : 
181.1,173 
[M-H]- 
[M+H]+ 
[M-H2O]
+ 
[M-COOH]+ 
[Proline+H]+ 
Pyroglutamyl 
proline1 
Urine 
Plasma 
NS/Malting 
26 166.12 1.13  [M+H]+ Hordenine1 Urine NS/Barley 
27 230.053 
232.066 
1.01  
 
ESI-:150.1, 
106.1,79.9 
[M-H]- 
[M+H]+ 
[M-Sulfate]- 
N-methyl tyramine 
sulfate2 
  
28 182.082 0.78 
 
 
ESI+: 119.1, 
136.1,123, 
165.1 
[M+H]+ Tyrosine1 Plasma NS/Barley 
 
29 132.102 0.91  
ESI+: 86.1 
[M+H]+ Iso/Leucine1 Plasma NS/Barley 
 
30 161.044 1.79  
ESI-: 
143,101 
71.1  
[M-H]- 2-ethyl malate2 Urine NS/ 
Fermentation 
 
 
Identification of metabolites associated with beer intake. 
*identification level, ** source of unconjugated compound, S: Specific to beer intake; NS: Not specific to beer 
intake, UI: Unidentified 
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Metabolites originating from hops: The identified metabolites originating from hops were IAAs and 
their oxidation and degradation products (Table 2, Metabolites 1 to 11). Detailed description of 
identification based on MS/MS is provided in the Supplementary material (Text S-2, Figure S-5 and S-
6). IAAs, iso-cohumulone and the mixture of iso-humulone and iso-adhumulone were identified as 
markers of beer intake both in urine and plasma with very similar excretion profiles. Figure 2 illustrates 
the excretion profiles of iso-cohumulone after consumption of 330 mL of test drinks. In accordance to 
the measured IAA concentrations in test beers (Figure 2C), IAAs in urine and plasma were the highest 
following consumption of SB. In plasma they dropped rapidly within 3 h, on the other hand, IAAs 
peaked later in urine (pooled urine within 1.5-3 h) and were still present in urine collected from 3 h up 
to 21 h.  
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Figure 2. Iso-cohumulone excretion profiles in urine (A) plasma (B) and iso-cohumulone levels in test 
beers (C).  
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Metabolites originating from human metabolism: Major metabolites were related to IAA 
biotransformation products and the same conjugates were recorded both for iso-cohumulone and iso-
ad/humulones (Table 2, Metabolites 12 to 23). Three related groups of conjugates were observed with 
addition of 29.98 Da (equal to addition of NO or CH2O; metabolites 12 and 13), 45.98 Da (equal to 
NO2 or CH2O2; metabolites14 and 15) and 166.99 Da (metabolites 16 and 17) to iso-cohumulone and 
iso-ad/humulone. We speculate that these metabolites are oxidation and methylation products as well as 
cysteine adducts of isocohumulone and iso/adhumulone. Urinary excretion profiles of the IAA 
conjugates were similar to those of IAAs (Figure 2). Metabolites 15 and M16 were still present at high 
levels in urine collected between 3 and 21 h, indicating that the peak of excretion of those metabolites 
was later than 3 h after intake (Figure S-8). 
Metabolites 18 to 22 (Table 2) were products of phase II metabolism (glucuronides and sulfates) based 
on their fragmentation patterns, yet the identity of the biotransformed beer components remains 
unknown. Metabolites 20 to 22 were phase II (glucuronide and sulfate) metabolites of the same 
compound and their fragmentation pattern revealed the presence of a thiol group. Furthermore, one 
cysteine mercapturic acid conjugate (Metabolite 23) is detected as a urinary marker. In terms of 
excretion profiles, all of them peaked in urine collected within 1.5 to 3 h. The products were not 
specific to the beer intake as they were also present after intake of C, albeit at much lower levels 
(Figure S-8).   
Metabolites originating from wort and fermentation: The identified metabolites are given in Table 2 
(Metabolites 24 to 30). The only metabolite originating from wort that is detected in both urine and 
plasma was pGlu-Pro. NMR based structure elucidation of pGlu-Pro is described in Figure S-9. The 
urinary excretion profile is given in Figure 3A with the highest excretion level around 3 h following 
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beer intake. The pGlu-pro was also detected in urine samples prior to the test meals and did not 
fluctuate following the consumption of C drink, indicating that it probably is a constituent of foods 
other than beer/wort or even that it is formed endogenously, but levels after beer intake are 
significantly higher. Hordenine, maltose (or an isomer) and NMT sulfate are identified as markers of 
beer intake in urine. Hordenine had already reached its maximum excretion level 0-1.5 h after intake, 
whereas maltose and NMT sulfate peaked in urine collected between 1.5-3 h and 3-21 h, respectively 
(Figure 3B, Figure S-10). Hordenine and NMT were present in the urine of the a few subjects prior to 
beer intake albeit with lower levels.  
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Figure 3. Urinary excretion profiles of pGlu-pro (A), NMT sulfate (B) and 2-ethyl malate (C). 
In plasma, isoleucine, leucine and tyrosine are identified as metabolites originating from wort and 
associated with beer intake. The excretion profile of tyrosine is shown in Figure S-11, in agreement 
with tyrosine concentration in beer. Both tyrosine and isoleucine/leucine were observed as rapidly 
absorbed metabolites.  
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In relation to fermentation, 2-ethyl malate is identified as a metabolite associated to beer intake in 
urine. It is excreted rather late compared to metabolites from hops and wort, with a reasonable high 
excretion between 3-21 h (Figure 3C).     
Selection of metabolites for the aggregated beer biomarker 
None of the beer intake markers discovered in this study was sufficiently specific or sensitive as single 
biomarkers to assess beer intake. The major issue with metabolites originating from hops (e.g. IAAs) is 
not specificity (see baseline levels, Figure 2) but sensitivity because they are not stable and several 
degradation products were also identified in urine at varying amounts. The issue with metabolites 
originating from wort or fermentation was that they were observed as markers of effect rather than 
exposure in the sense that they were present already at baseline but increased following beer intake. 
Hence none of the markers identified are specific to beer intake per se (see baseline levels, Figure 3). 
For the aggregated beer intake biomarker we selected one metabolite from each raw material (hops and 
barley) and production process (malting and fermentation) and established a compliance biomarker 
model for detection of beer intake based on MSt1. To overcome the issue with variable degradation of 
IAAs as representative of hops derived metabolites we used the sum of iso-cohumulone and iso-
ad/humulones and their major degradation products, tricyclocohumol and tricyclohumol. NMT sulfate 
was selected representing barley and pGlu-pro to represent heat treatment during malting. Fermentation 
was represented by 2-ethyl malate since this compound is not removed in de-alcoholization processes 
to produce light and non-alcoholic beers.  
Figure 4 demonstrates how the calibration model performs in terms of distinguishing samples after beer 
intake from the control time points and/or periods for calibration and validation sets. The scores plot of 
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the first component (Figure 4A) demonstrates that the calibration model provides correct prediction of 
the classes as control and beer groups for the samples from MSt2 (open circles in Figure 4A) for urine 
collected up to 12 h. Testing the same calibration model on urine samples collected from 12 to 24 h 
(MSt2), resulted in 0 sensitivity such that all the samples collected more than 12 hours after beer intake 
were wrongly classified as control samples (Figure S-12). This suggests that metabolites associated 
with beer intake were already excreted at 12 h. Therefore, the calibration model is valid for detection of 
beer intake up to 12 h post consumption as well as in 24 h pooled urine samples.  
 
Figure 4 (A) PLSDA scores plot of the first component. The calibration model is developed using the 
measurements of four metabolites for samples from the meal study 1 (filled circles) and the model is 
tested with samples from meal study 2 (open circles). C and B refer to control samples and 24 h pooled 
samples from the meal the meal study 1, respectively. Ctest and Btest refer to the samples before and 
collected up to 12 h following beer intake from meal study 2 (B) ROC curve describing the 
performance of the PLSDA model in terms of predicting beer intake for calibration (CV) and test set 
(TV) samples, respectively. 
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In order to assess the importance of each metabolite, we removed one of the four metabolites at a time 
and the calibration model still performed efficiently in terms of separating beer drinkers from control, 
thus none of the metabolites is individually crucial for the prediction. 
Discussion 
Accurate assessment of food intake is central in nutrition research and identification of specific food 
intake biomarkers is therefore a promising way ahead. Finding single biomarkers for complex foods 
like beer is difficult because each component in the food may be used also in other foods. The strategy 
described in the current study is therefore to derive aggregated biomarkers for complex foods adding 
the best markers for each component and processing step to improve the resulting biomarker specificity 
and sensitivity. Our cross-over meal study provided many markers associated with recent beer intake, 
particularly in urine, reflecting the metabolomes of beer, as well as metabolites originating from their 
human metabolism (Table 2). Beer metabolome is characterized by compounds originating from its raw 
materials, barley and hops, and their transformation products derived upon malting and fermentation. 
Each of the raw materials and processes flag specific compounds in urine and plasma. However, these 
are either present in other foods or unstable. Therefore individually they lack the specificity and 
sensitivity needed for intake biomarkers.  
IAAs from hops have been previously suggested as biomarkers of beer intake as they are specific to 
beer11, 12, 31. Although IAAs provided high sensitivity and specificity for detection of beer intake up to 
21 h for MSt1, they were not even detected after intake of low hops beer (MSt2). This is attributed not 
only to the low hops content of the test beer but also to formation of several oxidative degradation 
products of IAAs32, 33 underlining their instability. Tentatively identified degradation products of trans-
IAA in urine were tri- and tetra-cyclohumenes and tri-cyclohumols14, 34 whereas, mono- and di-
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hydroxylated humulones and humulinones appeared as oxygen-dependent degradation products of both 
cis- and trans-IAAs33. Indeed, only tricyclohumols were detected in low hops beer (MSt2), which has 
also been shown previously to be one of the major degradation products34. Therefore, using IAAs as 
single biomarkers of beer intake is not feasible since consumption of longer-term stored beers and beer 
varieties with low hops content may result in total degradation and therefore to low sensitivity for 
assessment of beer intake. Instead, the sum of IAAs and their major degradation products (e.i. tri-
cyclohumols) as a single biomarker provides a better predictor of beer intake as potential loss of IAAs 
is partially compensated by formation of tri-cyclohumols. Although validating this biomarker in MSt2 
provided high sensitivity and specificity (AUC =1), further studies including diverse types of beer and 
different storage periods are required for final validation. Our results also suggest that after ingestion 
IAAs are oxidized into metabolites, which could be tentatively identified based on fragmentation 
patterns (Table 2). The oxidized IAA metabolites are compounds similar to products of degradation 
during storage35. It is difficult to discriminate between phase I metabolism and storage-induced 
oxidation of IAA as the products have very similar structural characteristics but IAA oxidation is much 
accelerated after ingestion indicating enzyme-mediated formation. Oral administration of IAAs to 
rabbits lead to recovery of less than 6% of the dose as such metabolites, suggesting that IAAs may also 
be subject to other kinds of metabolism16. Indeed, we observed unidentified conjugation products of 
IAAs formed from oxygenated IAAs by methylation and cysteine conjugation. Further isolation and 
structure elucidation is required to verify these structures. Some beer brands use hydrogenated hops 
extracts, which renders the IAAs more stable, however it is uncertain whether these are used 
exclusively since their organoleptic properties do not exactly match those of the normal hops extract36. 
Adding markers for these compounds might be needed to cover some more unusual brands of beer. 
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The wort-derived beer intake markers were present in barley or formed during the malting/boiling 
process; therefore they may also be found in other barley containing foods, limiting their specificity. 
pGlu-pro was increased after beer intake, potentially due to a high content of proline in barley. pGlu-
pro may be formed upon heating of the barley sprouts during malting or wort boiling. Pyroglutamyl 
peptides have been suggested to act on inflammatory diseases16, 37, 38 and have been shown to exhibit an 
antidepressant-like effect in mice39. To our knowledge, pGlu-Pro has not previously been observed in 
beer samples or associated with an increase in blood or urine after beer intake. The sulfate conjugate of 
NMT is another wort-derived compound, potentially formed through phase II metabolism in the plant 
or during the malting process. NMT is produced by N-methylation of tyramine, which is further 
methylated to hordenine40. Hordenine is suggested as a qualitative marker of beer intake41, yet its 
excretion profile after intake of other barley containing foods should be investigated since it may not be 
possible to discriminate beer intake from intake of other barley containing diets. 
Malic acid, particularly in the form of di-ethyl malate is widely described as a constituent of alcoholic 
beverages42, 43, yet according to our knowledge, 2-ethyl malate has not previously been described in 
beer. We could also confirm its presence in wine and cider samples (data not shown), indicating that it 
is not specific to beer but to fermented beverages. 2-ethyl malate is probably formed through 
esterification of malic acid with ethanol, followed by partial rearrangement44 indicating that non-
alcoholic food fermentation is probably not a source of its formation.  
NMT sulfate, pGlu-pro and 2-ethyl malate were each detected in the urine of some subjects prior to 
intake of the test drink, suggesting intake from other food sources. Therefore, none of the single 
metabolites were sufficiently sensitive and specific for assessment of beer intake. Yet an aggregated 
biomarker characterizing the beer metabolome (i.e. its raw materials and the malting and brewing 
processes) provided a unique pattern. The four metabolites - NMT sulfate originating from barley, 2-
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ethyl malate originating from fermentation, pGlu-Pro originating from malting, and the sum of IAAs 
and their major degradation products (tricyclo-co- and -ad-humols) originating from hops – were used 
to establish an aggregated biomarker. It is crucial to validate new biomarkers with independent 
controlled trials as well as samples from observational studies45. Therefore, we utilized MSt2 for 
validation of the calibration model. The calibration model efficiently predicted beer intake up to 12 h 
(AUC = 1, Figure 4B); this set of four metabolites therefore provides an excellent aggregated 
biomarker for detection of beer intake. When we removed any one of the four metabolites from the 
aggregated biomarker, the calibration models performed equally well, suggesting that none of the 
individual metabolites are crucial for the model and that the aggregated approach is very robust. 
Other compounds originating from hops, such as reduced derivatives of IAAs and prenylated phenols 
have been suggested previously as urinary and blood biomarkers of beer intake 13, 31, 46. Isoxanthohumol 
was shown to be stable even after 10 years of storage, making it a suitable biomarker candidate. In our 
study, isoxanthohumol was only identified in hops extracts and beer samples (level 1), but not in urine 
and plasma (data not shown). This may be related to the low concentration of isoxanthohumol in urine 
and plasma; prenylated hops phenol glucuronide conjugates accounted for only 2% of the dose 47, 48. 
The gut microbial biotransformation of xanthohumol to prenylnaringenin in humans has been shown to 
vary from 0-100% between individuals49. This may also explain the relatively low sensitivity observed 
previously for this marker 46.  
Conclusions 
The concept of aggregated biomarkers proposed here may find widespread use to solve the problems of 
overlapping markers for intakes of many foods and especially for processed foods and whole diets. A 
recent study demonstrated that aggregated biomarkers provide higher sensitivity and specificity for 
intake of sugar sweetened beverages compared to single biomarkers50. Further development of this 
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concept will be to move it from the stage of providing qualitative markers to actually estimating the 
amount ingested and the time elapsed since ingestion. This should eventually be possible based on the 
different kinetics of the individual metabolites included in the aggregated biomarkers. 
In conclusion, we were able to segregate metabolites that are increased following beer intake into 
compounds originating from hops, wort, fermentation, and human metabolism. The majority of beer-
specific compounds originate from hops, but many of these are chemically unstable limiting their 
usefulness as single biomarkers. Many of the suggested biotransformation products of IAAs are novel, 
yet still need to be fully structurally characterized. We propose that wort and fermentation products 
may provide signature markers of beer intake in combination with one or more hops-specific marker. 
Therefore, we have shown here that an aggregated biomarker model based on a set of three out of four 
of these signature biomarkers was able to completely discriminate between samples collected after beer 
intake in an independent study with high sensitivity and specificity. It still remains to be shown that the 
aggregated biomarker of beer intake proposed herein is sensitive and specific in an observational 
setting and whether adjustments may be needed, e.g. adding markers for optional beer components 
such as reduced IAAs, caramel, wheat, corn, etc. 
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Figure S-1. SSQ distribution calculated by permuting the class assignments and the SSQ calculated for 
original class assignments for time and test drink effects.  
Figure S-2.  SSQ distribution calculated by permuting the class assignments and the SSQ calculated 
for original class assignments for time–test drink interaction. 
Text S-1. Identification of significant factors in the model  
Figure S-3. ASCA decomposition of urine LC-MS profiles.  SCA scores plots for (a) test drink, (b) 
time and (c) interaction of test drink and time for PC1.  
Figure S-4. ASCA decomposition of plasma LC-MS profiles.  SCA scores plots for (a) test drink, (b) 
time and (c) interaction of test drink and time for PC1.  
Table S-1. Unknown metabolites associated with consumption of test beers. 
Table S-2. Unknown metabolites associated with consumption of test beers. 
Text S-2. Identification of hops-derived metabolites 
Figure S-5. Extracted ion chromatogram for iso-cohumulone in ICS-I3, hops extract stored for 4 
months, fresh hops extract, test beer (SB) and urine sample 3 hours after consumption of the test beer 
(SB)    
Figure S-6. LC-MS/MS spectrum at 20V (ESI-) of iso-cohumulone and iso-/tricyclocohumene. 
Figure S-7. Urinary excretion profiles of metabolites originating from hops.   
Figure S-8. Urinary excretion profiles of unknown metabolites originating from human 
biotransformation observed after beer intake. 
Figure S-9. NMR identification of pyroglutamyl-proline with 1H and 13C chemical shifts for the 
aliphatic CH groups in UPLC fraction containing several molecular species.  . 
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Figure S-10. Urinary excretion profiles of maltose originating from wort 
Figure S-11. Tyrosine excretion profiles in plasma (a) and their corresponding levels in the test beers 
(b).   
Figure S-12. PLSDA model developed including pooled 24 h samples from MSt1 and the performance 
of the model in terms of detection of beer intake between 12 and 24 h for MSt2. 
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Figure Legends 
Figure 1. SCA score plot of the test drink matrix for both the urine (top) and plasma (bottom) 
metabolic profiles. An SCA model was applied to the effect matrix obtained from the ANOVA 
decomposition. 
Figure 2. Iso-cohumulone excretion profiles in urine (A) plasma (B) and test beer levels (C).  
Figure 3. Urinary excretion profiles of pGlu-pro (A), NMT sulfate (B) and 2-ethyl malate (C). 
Figure 4 (A) PLSDA scores plot of the first component. The calibration model is developed using the 
measurements of four metabolites for samples from the meal study 1 (filled circles) and the model is 
tested with samples from meal study 2 (open circles). C and B refer to control samples and 24 h pooled 
samples from the meal the meal study 1, respectively. Ctest and Btest refer to the samples before and 
collected up to 12 h following beer intake from meal study 2 (B) ROC curve describing the 
performance of the PLSDA model in terms of predicting beer intake for calibration (CV) and test set 
(TV) samples, respectively. 
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Table Legends 
Table 1. Participant characteristics of MSt1 and MSt2 at the time of enrollment 
Table 2. Identified plasma and urine metabolites originating from beer raw materials hops and wort, 
fermentation process and human and/or microbial biotransformation of beer components. 
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